Prime Medicine Reports Director Changes and Officer Appointments
Ticker: PRME · Form: 8-K · Filed: May 19, 2025 · CIK: 1894562
| Field | Detail |
|---|---|
| Company | Prime Medicine, Inc. (PRME) |
| Form Type | 8-K |
| Filed Date | May 19, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, management-change
TL;DR
Prime Medicine shakes up board, appoints new execs.
AI Summary
Prime Medicine, Inc. filed an 8-K on May 19, 2025, reporting on the departure of a director, the election of new directors, and the appointment of certain officers. The filing also includes information on compensatory arrangements for certain officers and other events, with a report date of May 16, 2025.
Why It Matters
Changes in board composition and executive appointments can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — This filing primarily concerns corporate governance changes and does not appear to involve significant financial transactions or operational disruptions.
Key Players & Entities
- Prime Medicine, Inc. (company) — Registrant
- 0001894562 (company) — Central Index Key
- 001-41536 (company) — SEC File Number
- 60 First Street Cambridge, MA 02141 (company) — Business Address
FAQ
Who departed from the board of directors at Prime Medicine, Inc.?
The filing indicates the departure of a director, but the specific name is not provided in the excerpt.
When was the report filed with the SEC?
The report was filed on May 19, 2025.
What is the exact name of the registrant?
The exact name of the registrant is Prime Medicine, Inc.
What is the principal executive office address for Prime Medicine, Inc.?
The principal executive offices are located at 60 First Street, Cambridge, MA 02141.
What is the SIC code for Prime Medicine, Inc.?
The Standard Industrial Classification (SIC) code for Prime Medicine, Inc. is 2836, which corresponds to BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 19, 2025 regarding Prime Medicine, Inc. (PRME).